The T cell antigen receptor: the Swiss army knife of the immune system

The mammalian T cell receptor (TCR) orchestrates immunity by responding to many billions of different ligands that it has never encountered before and cannot adapt to at the protein sequence level. This remarkable receptor exists in two main heterodimeric isoforms: αβ TCR and γδ TCR. The αβ TCR is expressed on the majority of peripheral T cells. Most αβ T cells recognize peptides, derived from degraded proteins, presented at the cell surface in molecular cradles called major histocompatibility complex (MHC) molecules. Recent reports have described other αβ T cell subsets. These ‘unconventional’ T cells bear TCRs that are capable of recognizing lipid ligands presented in the context of the MHC‐like CD1 protein family or bacterial metabolites bound to the MHC‐related protein 1 (MR1). γδ T cells constitute a minority of the T cell pool in human blood, but can represent up to half of total T cells in tissues such as the gut and skin. The identity of the preferred ligands for γδ T cells remains obscure, but it is now known that this receptor can also functionally engage CD1‐lipid, or immunoglobulin (Ig) superfamily proteins called butyrophilins in the presence of pyrophosphate intermediates of bacterial lipid biosynthesis. Interactions between TCRs and these ligands allow the host to discriminate between self and non‐self and co‐ordinate an attack on the latter. Here, we describe how cells of the T lymphocyte lineage and their antigen receptors are generated and discuss the various modes of antigen recognition by these extraordinarily versatile receptors.

[1]  D. Raulet,et al.  NK1.1+ T Cells in the Liver Arise in the Thymus and Are Selected by Interactions with Class I Molecules on CD4+CD8+ Cells1 , 2000, The Journal of Immunology.

[2]  Arne Svejgaard,et al.  Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  James McCluskey,et al.  Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor , 2012, The Journal of experimental medicine.

[4]  S. Bauer,et al.  Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. , 1998, Science.

[5]  N. K. Williams,et al.  Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells , 2013, Nature Immunology.

[6]  Hongbin He,et al.  Identification of Human T Cell Receptor γδ-recognized Epitopes/Proteins via CDR3δ Peptide-based Immunobiochemical Strategy* , 2008, Journal of Biological Chemistry.

[7]  Gerd Ritter,et al.  Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains , 2002, Nature Immunology.

[8]  Mark M. Davis,et al.  Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. , 2008, Immunity.

[9]  J. E. Brewer,et al.  T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells , 2015, Clinical and experimental immunology.

[10]  A. Singer,et al.  MHC restriction is imposed on a diverse T cell receptor repertoire by CD4 and CD8 co-receptors during thymic selection. , 2012, Trends in immunology.

[11]  D. Golan,et al.  Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. , 1995, Immunity.

[12]  Natalie A. Borg,et al.  CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor , 2007, Nature.

[13]  Gongyi Zhang,et al.  γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation. , 2014, Molecular immunology.

[14]  A. Sewell,et al.  Structural basis for ineffective T-cell responses to MHC anchor residue-improved “heteroclitic” peptides , 2014, European journal of immunology.

[15]  Yvonne McGrath,et al.  Monoclonal TCR-redirected tumor cell killing , 2012, Nature Medicine.

[16]  Monoclonal T-cell receptor drugs pique pharma's interest , 2013, Nature Biotechnology.

[17]  E. Adams,et al.  Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. , 2005, Science.

[18]  Jamie Rossjohn,et al.  A conserved human T cell population targets mycobacterial antigens presented by CD1b , 2013, Nature Immunology.

[19]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[20]  James McCluskey,et al.  T cell antigen receptor recognition of antigen-presenting molecules. , 2015, Annual review of immunology.

[21]  E. Adams,et al.  γδ T Cell Receptors Recognize the Non-classical Major Histocompatibility Complex (MHC) Molecule T22 via Conserved Anchor Residues in a MHC Peptide-like Fashion* , 2012, The Journal of Biological Chemistry.

[22]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[23]  D. Sinderen,et al.  T-cell activation by transitory neo-antigens derived from distinct microbial pathways , 2014, Nature.

[24]  David L Porter,et al.  Chimeric antigen receptor therapy for cancer. , 2014, Annual review of medicine.

[25]  Zhiping Weng,et al.  Cutting Edge: Evidence for a Dynamically Driven T Cell Signaling Mechanism , 2012, The Journal of Immunology.

[26]  Jamie Rossjohn,et al.  Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor , 2012, Nature Immunology.

[27]  A. Sewell,et al.  Coreceptor CD8-driven modulation of T cell antigen receptor specificity. , 2007, Journal of theoretical biology.

[28]  F. V. Laethem,et al.  Lck Availability during Thymic Selection Determines the Recognition Specificity of the T Cell Repertoire , 2013, Cell.

[29]  J. Yang,et al.  Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptor. , 2011, Blood.

[30]  D. Kabelitz,et al.  TCR trans-Rearrangements: Biological Significance in Antigen Recognition vs the Role as Lymphoma Biomarker , 2006, The Journal of Immunology.

[31]  J. Drijfhout,et al.  Structural basis of human β-cell killing by CD8+ T cells in Type 1 diabetes , 2011, Nature Immunology.

[32]  Carrie R Willcox,et al.  Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor , 2012, Nature Immunology.

[33]  R. Hodes,et al.  A Novel T Cell Subset with Trans-Rearranged Vγ-Cβ TCRs Shows Vβ Expression Is Dispensable for Lineage Choice and MHC Restriction , 2014, The Journal of Immunology.

[34]  Jamie Rossjohn,et al.  CD1d-lipid antigen recognition by the γδ TCR , 2013, Nature Immunology.

[35]  Olivier Michielin,et al.  Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+ T Cell Responsiveness* , 2012, The Journal of Biological Chemistry.

[36]  D. Wiest,et al.  The TCR ligand-inducible expression of CD73 marks γδ lineage commitment and a metastable intermediate in effector specification , 2014, The Journal of experimental medicine.

[37]  G. Gao,et al.  Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor* , 2009, The Journal of Biological Chemistry.

[38]  Damien Picard,et al.  Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells. , 2013, Immunity.

[39]  Mark M. Davis,et al.  Deconstructing the Peptide-MHC Specificity of T Cell Recognition , 2014, Cell.

[40]  M. Nishimura,et al.  Structural basis for the recognition of mutant self by a tumor-specific, MHC class II–restricted T cell receptor , 2007, Nature Immunology.

[41]  P. Marrack,et al.  Evolutionarily conserved features contribute to αβ T cell receptor specificity. , 2011, Immunity.

[42]  Mark M Davis,et al.  Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. , 2013, Immunity.

[43]  S. Carding,et al.  γδ T cells: functional plasticity and heterogeneity , 2002, Nature Reviews Immunology.

[44]  A. Singer,et al.  αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. , 2012, Immunity.

[45]  L. K. Ely,et al.  The molecular basis of TCR germline bias for MHC is surprisingly simple , 2009, Nature Immunology.

[46]  Olivier Lantz,et al.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.

[47]  Adam Bagg,et al.  Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. , 2013, Blood.

[48]  James E. Crooks,et al.  The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. , 2014, Immunity.

[49]  Jennifer Maynard,et al.  Structural evidence for a germline-encoded T cell receptor–major histocompatibility complex interaction 'codon' , 2007, Nature Immunology.

[50]  Fiona Ross,et al.  NKT cell activation by diverse antigens and antigen-presenting cells , 2013 .

[51]  A. Hayday,et al.  Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells. , 2011, Immunity.

[52]  James McCluskey,et al.  A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells , 2014, The Journal of experimental medicine.

[53]  J. McCluskey,et al.  MR1 presentation of vitamin B-based metabolite ligands. , 2015, Current opinion in immunology.

[54]  D. Price,et al.  A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides* , 2011, The Journal of Biological Chemistry.

[55]  A. Sewell,et al.  CD8 Controls T Cell Cross-Reactivity , 2010, The Journal of Immunology.

[56]  G. De Libero,et al.  Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells , 2003, The Journal of experimental medicine.

[57]  Natalie A Borg,et al.  High Resolution Structures of Highly Bulged Viral Epitopes Bound to Major Histocompatibility Complex Class I , 2005, Journal of Biological Chemistry.

[58]  L. K. Ely,et al.  T-cells behaving badly: structural insights into alloreactivity and autoimmunity. , 2008, Current opinion in immunology.

[59]  J. McCluskey,et al.  Allelic polymorphism in the T cell receptor and its impact on immune responses , 2010, The Journal of experimental medicine.

[60]  J. McCluskey,et al.  Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. , 2008, Blood.

[61]  K. Garcia,et al.  Reconciling views on T cell receptor germline bias for MHC. , 2012, Trends in immunology.

[62]  Bent K Jakobsen,et al.  Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells , 2013, Science Translational Medicine.

[63]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[64]  Wei He,et al.  Ectopically Expressed Human Tumor Biomarker MutS Homologue 2 Is a Novel Endogenous Ligand That Is Recognized by Human γδ T Cells to Induce Innate Anti-tumor/Virus Immunity* , 2012, The Journal of Biological Chemistry.

[65]  D. Häussinger,et al.  A novel self-lipid antigen targets human T cells against CD1c+ leukemias , 2014, The Journal of experimental medicine.

[66]  Jamie Rossjohn,et al.  αβ T cell antigen receptor recognition of CD1a presenting self lipid ligands , 2015, Nature Immunology.

[67]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[68]  K. Wucherpfennig,et al.  T cell receptor recognition of self and foreign antigens in the induction of autoimmunity. , 2011, Seminars in immunology.

[69]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[70]  O. Lantz,et al.  Double Positive Thymocytes Select Mucosal-Associated Invariant T Cells , 2013, The Journal of Immunology.

[71]  E. Adams,et al.  Crystal Structure of V delta 1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human gamma delta T Cells. , 2013 .

[72]  G. Lal,et al.  Role of gamma-delta ( gd ) T cells in autoimmunity , 2015 .

[73]  Andrew K. Sewell,et al.  Human TCR-Binding Affinity is Governed by MHC Class Restriction1 , 2007, The Journal of Immunology.

[74]  A. Rao,et al.  Binding of antigen in the absence of histocompatibility proteins by arsonate-reactive T-cell clones , 1984, Cell.

[75]  James McCluskey,et al.  Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability , 2010, Proceedings of the National Academy of Sciences.

[76]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[77]  M. Probst-Kepper,et al.  Conformational Restraints and Flexibility of 14-Meric Peptides in Complex with HLA-B*35011 , 2004, The Journal of Immunology.

[78]  B. Bloom,et al.  Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.

[79]  M. Karplus,et al.  Crystal Structures of Two Closely Related but Antigenically Distinct HLA-A2/Melanocyte-Melanoma Tumor-Antigen Peptide Complexes1 , 2001, The Journal of Immunology.

[80]  R. Phillips,et al.  Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor , 2008, Nature Medicine.

[81]  S. Porcelli,et al.  Recognition of a lipid antigen by GDI-restricted αβ+ T cells , 1994, Nature.

[82]  Wei He,et al.  Ectopic Expression of Human MutS Homologue 2 on Renal Carcinoma Cells Is Induced by Oxidative Stress with Interleukin-18 Promotion via p38 Mitogen-activated Protein Kinase (MAPK) and c-Jun N-terminal Kinase (JNK) Signaling Pathways* , 2012, The Journal of Biological Chemistry.

[83]  G. Lal,et al.  Role of gamma‐delta (γδ) T cells in autoimmunity , 2015, Journal of leukocyte biology.

[84]  G. Besra,et al.  Human and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen Complex* , 2012, The Journal of Biological Chemistry.

[85]  K. Christopher Garcia,et al.  Structure of a γδ T Cell Receptor in Complex with the Nonclassical MHC T22 , 2005, Science.

[86]  J. Drijfhout,et al.  Structural basis for the killing of human beta cells by CD 8 + T cells in type 1 diabetes , 2012 .

[87]  B. Jakobsen,et al.  Different affinity windows for virus and cancer‐specific T‐cell receptors: Implications for therapeutic strategies , 2012, European journal of immunology.

[88]  G. Anderson,et al.  Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: What we learn from intrathymic migration , 2015, European journal of immunology.

[89]  A. Sewell,et al.  Peptide length determines the outcome of TCR/peptide-MHCI engagement. , 2013, Blood.

[90]  F. V. Laethem,et al.  Deletion of CD4 and CD8 Coreceptors Permits Generation of αβT Cells that Recognize Antigens Independently of the MHC , 2007 .

[91]  R. Hohlfeld,et al.  Target Specificity of an Autoreactive Pathogenic Human γδ-T Cell Receptor in Myositis* , 2012, The Journal of Biological Chemistry.

[92]  Andrew K. Sewell,et al.  Why must T cells be cross-reactive? , 2012, Nature Reviews Immunology.

[93]  O. Lantz,et al.  Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.

[94]  C. Shapiro,et al.  Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cells. , 2014, Biochimica et biophysica acta.

[95]  Andrew K. Sewell,et al.  Genetic and Structural Basis for Selection of a Ubiquitous T Cell Receptor Deployed in Epstein-Barr Virus Infection , 2010, PLoS pathogens.

[96]  Yi Li,et al.  Directed evolution of human T-cell receptors with picomolar affinities by phage display , 2005, Nature Biotechnology.

[97]  Y. Tanaka,et al.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. , 1995, Nature.

[98]  M. Lan,et al.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[99]  D. Stuart,et al.  Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. , 1997, Nature.

[100]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[101]  H. Macdonald,et al.  T Cell Receptor δ Gene Rearrangement and T Early α (TEA) Expression in Immature αβ LineageThymocytes: Implications for αβ/γδ Lineage Commitment , 1996 .

[102]  M. Nei,et al.  Positive Darwinian selection promotes charge profile diversity in the antigen-binding cleft of class I major-histocompatibility-complex molecules. , 1990, Molecular biology and evolution.

[103]  K D Wittrup,et al.  Selection of functional T cell receptor mutants from a yeast surface-display library. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[104]  A. Sewell,et al.  T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions* , 2013, The Journal of Biological Chemistry.

[105]  A. Saghatelian,et al.  The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. , 2010, Immunity.

[106]  Raymond M. Welsh,et al.  No one is naive: the significance of heterologous T-cell immunity , 2002, Nature Reviews Immunology.

[107]  D. Wei,et al.  Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes , 2005, The Journal of experimental medicine.

[108]  Jean-Jacques Fournié,et al.  Structure of a human γδ T-cell antigen receptor , 2001, Nature.

[109]  S. Rosenberg,et al.  Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.

[110]  D I Stuart,et al.  An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. , 1996, Immunity.

[111]  James McCluskey,et al.  Recognition of vitamin B metabolites by mucosal-associated invariant T cells , 2013, Nature Communications.

[112]  James Robinson,et al.  The IPD and IMGT/HLA database: allele variant databases , 2014, Nucleic Acids Res..

[113]  A. Bendelac Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes , 1995, The Journal of experimental medicine.

[114]  Kristin Ladell,et al.  Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition , 2010, The Journal of Immunology.

[115]  S. Holland,et al.  The T-cell receptor is not hardwired to engage MHC ligands , 2012, Proceedings of the National Academy of Sciences.

[116]  R. Mariuzza,et al.  Crystal structure of a complete ternary complex of T-cell receptor, peptide–MHC, and CD4 , 2012, Proceedings of the National Academy of Sciences.

[117]  H. von Boehmer,et al.  The thymus selects the useful, neglects the useless and destroys the harmful. , 1989, Immunology today.

[118]  Yoshimasa Tanaka,et al.  Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells , 1995 .

[119]  L. Stern,et al.  A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands. , 2011, Immunity.

[120]  Roland Martin,et al.  Structure of a TCR with high affinity for self‐antigen reveals basis for escape from negative selection , 2011, The EMBO journal.

[121]  E. Adams,et al.  Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by αβ T cells , 2014, Proceedings of the National Academy of Sciences.

[122]  D. Zaller,et al.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. , 1997, Immunity.

[123]  G. De Libero,et al.  T cells specific for lipid antigens , 2012, Immunologic Research.

[124]  I. Spendlove,et al.  Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy , 2012, Clinical and experimental immunology.

[125]  R. Strong,et al.  Crystal structure of a γδ T-cell receptor specific for the human MHC class I homolog MICA , 2011, Proceedings of the National Academy of Sciences.

[126]  T. Jardetzky,et al.  Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. , 2002, Molecular cell.

[127]  A. Casrouge,et al.  A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .